The suzetrigine, which only acts on pain neurons, is the first innovation in analgesia in the last 20 years. "It stands out ...
Hundreds of Texas convenience stores are selling untested, highly addictive and potentially deadly drugs as over-the-counter ...
After nearly a decade of annual upticks in overdose deaths, the city saw a drop in 2023, the latest data available. Something ...
Authors Table of Contents Media Contact For general and media inquiries and to book our experts, please contact: [email protected] Harm reduction directly empowers people who use drugs to stay safer and ...
When prescribing opioids for acute pain, physicians should be attentive to a patient’s individual risk factors, according to ...
For the first time in decades, a new class of painkiller has been approved by the US Food and Drug Administration (FDA).
A new study led by researchers at the Harvard Pilgrim Health Care Institute found that a 2019 Medicare opioid safety policy showed initial reductions in opioid prescribing to high-risk populations.
Opioid prescriptions in the emergency department (ED) were associated with small increases in later opioid prescriptions and hospital admissions, found new research published in CMAJ (Canadian Medical ...
A good night's sleep often sets the stage for a positive day. But for the nearly quarter of American adults struggling with ...
Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...
A new study by the Substance Abuse and Mental Health Services Administration, a branch of the US Department of Health and ...